Ligand validation:4LKD

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 4LKD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4LKD_GAL_F_201	83%	46%	0.072	0.944	0.89	1.2	-	2	0	0	92%	0.9167
4LKD_GAL_A_201	76%	47%	0.087	0.939	0.91	1.13	-	2	1	0	92%	0.9167
4LKD_GAL_D_201	69%	46%	0.099	0.929	0.95	1.14	-	2	0	0	92%	0.9167
4LKD_GAL_E_201	68%	44%	0.103	0.93	0.9	1.24	-	2	0	0	92%	0.9167
4LKD_GAL_H_201	53%	47%	0.121	0.897	0.9	1.15	-	1	0	0	92%	0.9167
4LKD_GAL_C_201	50%	46%	0.121	0.885	0.95	1.12	-	1	0	0	92%	0.9167
4LKD_GAL_G_201	46%	46%	0.132	0.881	0.91	1.15	-	2	0	0	92%	0.9167
4LKD_GAL_B_201	44%	50%	0.129	0.872	0.85	1.07	-	2	0	0	92%	0.9167
4YW7_GAL_B_202	96%	66%	0.066	0.976	0.57	0.74	-	-	0	0	100%	1
1OKO_GAL_D_902	96%	56%	0.065	0.972	0.9	0.82	-	1	0	0	100%	0.6
4CP9_GAL_A_1123	92%	25%	0.058	0.962	1.3	1.72	1	6	0	0	92%	0.9167
4LKF_GAL_A_201	91%	55%	0.083	0.984	0.92	0.83	-	-	0	0	92%	0.9167
4LJH_GAL_A_203	85%	25%	0.065	0.946	2.36	0.74	2	-	0	0	92%	0.9167
5ELB_GAL_C_202	100%	58%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
4WWH_GAL_B_401	100%	61%	0.047	0.993	0.51	0.97	-	1	0	0	100%	1
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1
5DVJ_GAL_B_501	98%	40%	0.047	0.968	0.95	1.38	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.